Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination …
G Giammanco, A Moiraghi, C Zotti, S Pignato, SL Volti… - Vaccine, 1998 - Elsevier
The reactogenicity and immunogenicity of a tetravalent diphtheria-tetanus-acellular
pertussis-hepatitis B (DTPa-HB) vaccine (SmithKline Beecham) were studied in 565 infants …
pertussis-hepatitis B (DTPa-HB) vaccine (SmithKline Beecham) were studied in 565 infants …
[HTML][HTML] Inmunogenicidad y reactogenicidad de una vacuna de difteria, tétanos, pertussis acelular de contenido antigénico reducido (dTpa) en niños de 10 a 11 años …
K Abarca, F Valdivieso, M Potin, I Ibáñez… - Revista médica de …, 2002 - SciELO Chile
Background: New vaccination strategies are needed to control the increasing problem of
pertussis in teenagers and adults. Aim: To determine the immunogenicity and reactogenicity …
pertussis in teenagers and adults. Aim: To determine the immunogenicity and reactogenicity …
[HTML][HTML] Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization …
M Sancovski, N Mesaros, Y Feng… - Human vaccines & …, 2019 - Taylor & Francis
Reduced antigen diphtheria-tetanus-acellular pertussis (Tdap) vaccination is included in the
maternal immunization program in Brazil since September 2014. We investigated …
maternal immunization program in Brazil since September 2014. We investigated …
Immunogenicity and reactogenicity of a bicomponent and a tricomponent acellular pertussis-diphtheria-tetanus (DTaP) vaccine in primary immunization and as …
HJ Schmitt, S Müschenborn, S Wagner, M Knuf… - International Journal of …, 1996 - Elsevier
Objectives: To compare the immunogenicities and reactogenicities of bicomponent
(B)(pertussis toxoid, filamentous hemagglutinin) and tricomponent (T)(pertussis toxoid …
(B)(pertussis toxoid, filamentous hemagglutinin) and tricomponent (T)(pertussis toxoid …
Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of a Fully Liquid Combination Diphtheria–Tetanus Toxoid–Five-Component Acellular …
T Vesikari, SA Silfverdal, F Boisnard… - Clinical and Vaccine …, 2013 - Am Soc Microbiol
This study compared the levels of immunogenicity and safety of diphtheria–tetanus toxoid–
five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus …
five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and Haemophilus …
Controlled Study of aNew Five-Component Acellular Pertussis Vaccine in Adults and Young Children
JA Englund, WP Glezen, L Barreto - Journal of Infectious …, 1992 - academic.oup.com
A new five-component acellular pertussis (AP) vaccine containing 10 µLg of pertussis toxoid,
S µg of filamentous hemagglutinin, 5 jµ of combined agglutinogens 2 and 3, and 3 µg of …
S µg of filamentous hemagglutinin, 5 jµ of combined agglutinogens 2 and 3, and 3 µg of …
Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned
C Capiau, J Poolman, B Hoet, H Bogaerts, F Andre - Vaccine, 2003 - Elsevier
The widespread use of whole-cell pertussis vaccines in the second half of the 20th century
have reduced the incidence of the disease significantly. However, in some countries …
have reduced the incidence of the disease significantly. However, in some countries …
Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population
HF Tseng, LS Sy, L Qian, SM Marcy… - Clinical infectious …, 2013 - academic.oup.com
Background. Published data on the safety of tetanus-diphtheria-acellular pertussis vaccine
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age
M Blatter, LR Friedland, WM Weston, P Li, B Howe - Vaccine, 2009 - Elsevier
PURPOSE: This study was conducted to assess the immunogenicity and safety of a tetanus
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …
[HTML][HTML] Immunogenicity and antibody persistence of diphteria-tetanus-acellular pertussis vaccination in adolescents and adults: A systematic review of the literature …
R Squeri, C Genovese - Journal of Preventive Medicine and …, 2020 - ncbi.nlm.nih.gov
Materials and methods We prepared a review according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) with the aims of: a) describing the …
Systematic Reviews and Meta-Analyses (PRISMA) with the aims of: a) describing the …